Category: Biography

Suitability For Young Scientist Award

Ibrahim Iddrisu is a strong candidate for the Young Scientist Award, given his innovative research contributions and expertise in antimicrobial drug discovery, molecular microbiology, and biopharmaceutical research.Ibrahim has over six years of experience in microbiology research, focusing on developing novel therapeutics to combat multidrug-resistant pathogens. His PhD research at Alabama State University explores the antibiotic effects of CBD and phage tailspike proteins, an area of significant relevance to global healthcare challenges. His background in quality assurance, biopharmaceutical development, and production management further highlights his comprehensive expertise in both research and industry applications.

Education & Experience 🎓💼

PhD in Microbiology (2022–Present) – Alabama State University 🏫🔬
MPhil in Biotechnology (2017–2020) – University for Development Studies, Ghana 🏥🧪
BSc in Applied Biology (2012–2016) – University for Development Studies, Ghana 🌿🧬
Graduate Student Researcher (2022–Present) – Science of Hemp Research, ASU 🌿🔬
Graduate Teaching Assistant (2022–Present) – Alabama State University 📚👨‍🏫
Research Associate Intern (2023) – Oscity Labs, USA 🧪⚗️
Quality Assurance Officer Intern (2022) – CSIR Food Research Institute, Ghana 🏭✅
Production Manager (2020–2022) – Wa Fruit Juice Factory, Ghana 🏗️🥤
Postgraduate Research Assistant (2017–2019) – University for Development Studies, Ghana 🌍🦠

Professional Development 🚀🔍

Ibrahim has actively engaged in cutting-edge research, exploring novel antimicrobial strategies using CBD and phage-derived proteins to combat multidrug-resistant bacteria. His expertise in molecular microbiology and biotechnology extends to computational biology, microbial metabolomics, and bioinformatics. Beyond the lab, he has led production teams, ensuring regulatory compliance and optimizing workflows. Ibrahim has also contributed to sustainable innovations, developing lyophilized starter cultures and eco-friendly preservation techniques. His interdisciplinary collaborations in academia and industry have resulted in impactful publications, quality control improvements, and novel solutions in food safety, biopharmaceuticals, and microbiological research. 🧬📈🌍

Research Focus 🔬🦠

Ibrahim’s research revolves around antimicrobial drug discovery, focusing on CBD-based antibiotics, bacteriophage therapy, and microbial resistance mechanisms. His studies at Alabama State University explore the therapeutic effects of CBD and phage tailspike proteins on multidrug-resistant Salmonella strains, utilizing molecular biology, bioinformatics, and computational modeling. His previous work includes biopreservation techniques, lactic acid bacteria applications, and enzymatic activity in fermentation. Additionally, he has delved into food microbiology, gut microbiota studies, and regulatory quality assurance, bridging the gap between microbiology and sustainable biotechnology. His holistic approach integrates experimental, computational, and industrial microbiology for impactful innovations. 🌱🧪💊

Awards & Honors 🏅🎖️

Research Excellence Award – Alabama State University 🏆🔬
Best Presentation Award – International Conference on Microbiology 🗣️🏅
Graduate Research Fellowship – Science of Hemp Research, ASU 🎓💡
Innovation in Biotech Award – University for Development Studies 🌍🧬
Outstanding Teaching Assistant Recognition – Alabama State University 🏫👏

Publication Top Notes:

📌 **Mechanisms of Salmonella typhimurium Resistance to Cannabidiol** (🦠) | DOI: 10.3390/microorganisms13030551 | 👥

📌 **Cannabidiol Interactions with Outer Membrane Proteins in Salmonella Typhimurium LT2** (🧬) | DOI: 10.21203/rs.3.rs-4858257/v1 | 👥

📌 Influence of Fungicide Application on Rhizosphere Microbiota Structure and Microbial Secreted Enzymes in Diverse Cannabinoid-Rich Hemp Cultivars (🌱) | DOI: 10.3390/ijms25115892 |

📌 Prolonged CBD Pressure Mediates Higher Expression of flgA in Salmonella typhimurium (🔬) | DOI: 10.20944/preprints202405.1927.v1 | 👥

📌 Development and Evaluation of a Solar Milk Pasteurizer for the Savanna Ecological Zone of West Africa (☀️🥛) | DOI: 10.20944/preprints202405.1007.v1 | 👥

📌 The Interplay between 2-Arachidonoylglycerol and Anandamide Amidohydrolase in Neuropathy (🧠) | DOI: 10.20944/preprints202405.0771.v1 | 👥

📌 Typhoid Fever, Malaria and their Co-infection: A Review (🦟🤒) | DOI: 10.20944/preprints202405.0844.v1 | 👥

Prof. Songbing He | Tumor Immunology | Best Researcher Award

Published on 13/03/202513/03/2025 by Biotechnology Scientist

Prof. Songbing He | Tumor Immunology | Best Researcher Award

Prof. Songbing He | The First Affiliated Hospital of Soochow University | China

Dr. Songbing He is a distinguished colorectal cancer researcher 🏥 and surgeon 🔬 at The First Affiliated Hospital of Soochow University, China 🇨🇳. With a strong background in immunomodulation 🦠 and immunometabolism 🔥, he has contributed significantly to both basic and clinical research 📚. His work explores innovative treatments 💡 for colorectal cancer, integrating immunotherapy 💉 and metabolism-based interventions ⚡. Dr. He has held key positions in prestigious institutions, including Washington University in St. Louis 🇺🇸. His research has led to impactful publications 📝, accumulating over 200 citations 🔢. As a dedicated academic 🎓 and clinician 🏥, Dr. He continues to advance the field of gastrointestinal oncology 🏆.

Professional Profile:

Suitability for Best Researcher Award

Dr. Songbing He is a renowned researcher and surgeon specializing in colorectal cancer at The First Affiliated Hospital of Soochow University, China 🏥. His expertise in immunomodulation 🧬 and immunometabolism 🔥 has greatly advanced colorectal cancer research. His innovative approach 🚀—integrating immunotherapy 💉 with metabolism-based interventions—highlights his pioneering role in developing novel cancer treatment strategies.

Education & Experience 🎓💼

Ph.D. in Surgery (2009-2012) 🏥 – Soochow University, China
Master’s Degree in Surgery (2003-2006) 🩺 – Soochow University, China
Bachelor’s Degree in Clinical Medicine (1998-2003) 📚 – Jiangsu University, China
Research Fellow (2013-Present) 🔬 – Washington University in St. Louis, USA
Postdoctoral Researcher (2012-2013) 🧪 – Shanghai Jiao Tong University, China
Attending Doctor & Lecturer (2009-2013) 👨‍⚕️ – The First Affiliated Hospital of Soochow University
Resident & Teaching Assistant (2006-2009) 🏥 – The First Affiliated Hospital of Soochow University

Professional Development 🌎📖

Dr. He’s career is marked by continuous learning and global collaborations. At Washington University, he explored the intersection of nutrition, immunology, and colorectal cancer, fostering advancements in immunometabolism. His postdoctoral tenure at Shanghai Jiao Tong University further refined his expertise in tumor immunology. As a lecturer and attending physician, he has mentored young researchers and medical students, contributing to medical education. His participation in international conferences and editorial roles in scientific journals reflects his dedication to knowledge dissemination. Through innovative research and interdisciplinary collaborations, Dr. He remains at the forefront of colorectal cancer advancements.

Research Focus 🔬🦠

Dr. Songbing He’s research primarily revolves around colorectal cancer with a focus on tumor immunology and metabolism. He investigates how the immune system interacts with tumor cells and explores ways to manipulate these interactions for improved therapies. His expertise extends to immunometabolism, where he examines how metabolic changes within immune cells affect cancer progression. Additionally, he explores novel biomarkers for early detection and personalized treatment strategies. His work integrates basic science with clinical applications, bridging the gap between laboratory discoveries and patient care, ultimately aiming for more effective and less toxic cancer treatments.

Awards & Honors 🏆🎖

Outstanding Researcher Award 🏅 – Soochow University
Best Paper Award 📜 – International Colorectal Cancer Conference
Excellent Young Scholar Grant 💰 – National Natural Science Foundation of China
Top Reviewer Recognition 🏅 – Leading Oncology Journals
Travel Grant for Young Scientists ✈️ – International Immunology Congress

Publication Top Notes :

📖 Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity | 👥 928 citations | 🏛️ Cell Metabolism

📖 Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients | 👥 174 citations | 🏛️ International Journal of Molecular Sciences

📖 Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species | 👥 121 citations | 🏛️ Toxicology Letters

📖 Clinicopathologic Significance of HIF‐1α, CXCR4, and VEGF Expression in Colon Cancer | 👥 101 citations | 🏛️ Journal of Immunology Research

📖 Downregulation of enhancer of zeste homolog 2 (EZH2) is essential for the induction of autophagy and apoptosis in colorectal cancer cells | 👥 87 citations | 🏛️ Genes

📖 MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway | 👥 83 citations | 🏛️ International Journal of Molecular Medicine

Dr. Liang Luo | Nano-Biotechnology | Best Researcher Award

Published on 03/03/202503/03/2025 by Biotechnology Scientist

Dr. Liang Luo | Nano-Biotechnology | Best Researcher Award

Dr. Liang Luo | Harbin Institute of Technology | China

Luo Liang (罗亮) is a dedicated researcher in nano-biotechnology 🧬, intelligent construction 🏗️, and bridge engineering 🌉. Born in July 1996 in Ji’an, Jiangxi Province, China 🇨🇳, he is a Ph.D. candidate at Harbin Institute of Technology 🎓, specializing in artificial intelligence-driven smart infrastructure maintenance and nano-material applications for structural sustainability. He has contributed to national research projects integrating nano-biotechnology, self-healing materials, and AI-driven maintenance for bridges and urban infrastructure. With over 10 SCI-indexed publications 📖 in leading engineering and material science journals, he actively explores nano-engineered concrete, self-repairing bridge materials, and intelligent maintenance decision-making 🤖. Luo has also worked in the construction industry and assisted with national-level research and award applications.

Professional Profile:

Suitability for Best Researcher Award

Luo Liang demonstrates strong research potential in nano-biotechnology, intelligent construction, and bridge engineering. His interdisciplinary expertise, particularly in AI-driven smart infrastructure maintenance and nano-material applications, positions him as a valuable contributor to modern engineering challenges. His research aligns with the global push for sustainable and intelligent infrastructure solutions.

Education & Experience 🎓👨‍🔬

🔹 Ph.D. in Civil Engineering (2021-2025) – Harbin Institute of Technology 🏗️ (Focus: Nano-biotechnology in Smart Materials)
🔹 M.Sc. in Architecture & Civil Engineering (2018-2021) – South China University of Technology 🏛️ (Focus: High-performance Structural Nodes)
🔹 B.Sc. in Civil Engineering (2014-2018) – East China Jiaotong University 🚆 (Focus: Advanced Materials in Construction)

🔸 National Key R&D Program (2022-2025) – Artificial intelligence-driven nano-enhanced bridge maintenance 🛠️🔬
🔸 National Natural Science Foundation Project (2017-2021) – Self-healing high-performance structural nodes using nano-materials 🏢
🔸 China Resources Land (Guangzhou) Co., Ltd. (2019-2021) – Project design & planning with nano-coatings for buildings 🏠
🔸 Ph.D. Advisor Assistance (2021-Present) – Nano-material applications in bridge sustainability and repair 🏆

Professional Development 📚🚀

Luo Liang is at the forefront of nano-biotechnology applications in civil engineering 🔬. His research focuses on nano-engineered self-healing materials 🏗️, biocompatible coatings for bridges 🌉, and intelligent infrastructure monitoring 📡. By integrating nano-sensors, AI-driven predictive analytics 🤖, and biomimetic materials, he develops high-performance, sustainable structures. His work includes nano-reinforced concrete 🏢 for crack resistance, self-repairing polymer composites, and biodegradable construction materials 🌱. Actively publishing in top-tier SCI journals, he also contributes to national research projects and industrial collaborations 🏆. Passionate about nano-biotech innovations, he strives to enhance the future of smart, self-sustaining infrastructure 🚀.

Research Focus 🔬🏗️

Luo Liang specializes in nano-biotechnology and artificial intelligence-driven smart infrastructure 🤖. His work integrates nanomaterials, biological self-healing technologies, and big data analytics 📊 to develop autonomous maintenance systems 🏗️. Key research areas include:
🔹 Nano-enhanced bridge coatings for corrosion resistance ⚙️
🔹 Bio-inspired self-repairing concrete for crack healing 🏢
🔹 Nano-sensor networks for real-time bridge health monitoring 🌉
🔹 AI-driven material optimization for sustainability assessments 🌱
🔹 Ultra-high-performance nano-concrete (UHPC) with biodegradable reinforcements 🧬
🔹 3D printing of nanostructured materials for construction automation 🖥️

His goal is to create intelligent, self-sustaining, and durable infrastructure 🌎 using nano-biotechnology innovations.

Awards & Honors 🏅✨

🏆 National Ph.D. Scholarship & Inspirational Scholarship 🎓
🏅 Outstanding Student & Excellent Student Leader 🏫
🏅 Outstanding Graduate & Excellent Communist Party Member 🌟
🏗️ Second Prize – National University Bridge Design Competition 🥈
🎖️ Excellent Performance in Research & Academic Contributions 📖

Publication Top Notes:

📌 Stressing state analysis of multi-span continuous steel-concrete composite box girder – H Xiao, L Luo, J Shi, H Jiang, Z Wu | Engineering Structures | 📖 Cited by: 24

🏗 Experimental evaluation of mechanical properties and microstructure for recycled aggregate concrete collaboratively modified with nano-silica and mixed fibers – H Sun, L Luo, H Yuan, X Li | Construction and Building Materials | 📖 Cited by: 19

🔩 Parametric analysis and stiffness investigation of extended end-plate connection – L Luo, M Du, J Yuan, J Shi, S Yu, Y Zhang | Materials | 📖 Cited by: 18

🧱 Experimental study on flexural performance of ultra-high-performance concrete with recycled aggregate co-modified by nano-silica and steel fiber – L Luo, J Shi, J Wang, Y Qu, B Dai | Construction and Building Materials | 📖 Cited by: 14

⚡ Seismic behavior of extended end-plate connections subjected to cyclic loading on the top-side of the column – L Luo, J Qin, D Zhao, Z Wu | Materials | 📖 Cited by: 13

Prof. Yongli Song | Intestinal Microbiota | Best Researcher Award

Published on 28/02/202503/03/2025 by Biotechnology Scientist

Prof. Yongli Song | Intestinal Microbiota | Best Researcher Award

Prof. Yongli Song | Inner mongolia university | China

Professor Yongli Song is a distinguished researcher at Inner Mongolia University, specializing in sheep breeding 🐏 and intestinal microbiota 🦠. With a strong background in animal science, Professor Song has made significant contributions to the field, particularly in understanding intestinal diseases 💊. His research has been published in leading international journals, including Microbiome, Journal of Functional Foods, and Ecotoxicology and Environmental Safety 📚. Passionate about advancing livestock health and sustainability 🌱, he continues to explore the intricate relationship between gut microbiota and animal well-being, helping to shape the future of animal science and veterinary medicine.

Professional Profile:

Suitability for Best Researcher Award

Professor Yongli Song is a distinguished researcher in the field of animal science, with a particular focus on sheep breeding and intestinal microbiota. His contributions have significantly advanced the understanding of gut microbiota and intestinal diseases in livestock, which has profound implications for animal health, productivity, and sustainability.

Education & Experience 🎓🔬

Ph.D. in Animal Science 🐄 – Focused on sheep breeding & gut microbiota 🧬
Professor at Inner Mongolia University 🏛️ – Leading research in intestinal health and livestock genetics
Published in High-impact Journals 📖 – Microbiome, Journal of Functional Foods, Ecotoxicology and Environmental Safety
Collaborates with International Research Institutions 🌍 – Contributing to global advancements in livestock microbiome studies

Professional Development 🚀

Professor Song is deeply involved in innovative research exploring the interaction between intestinal microbiota and sheep health 🐏. His work aims to improve livestock productivity while reducing environmental impact 🌱. Through cutting-edge genomic and microbiome analysis 🧬, he has enhanced understanding of how diet and environment influence gut health. Professor Song actively mentors young researchers 👨‍🏫 and collaborates with industry leaders to implement sustainable agricultural practices 🌾. His continuous engagement in scientific conferences 🏅 and editorial activities ensures his expertise remains at the forefront of agricultural biotechnology and animal health research.

Research Focus 🔍

Professor Song’s research primarily explores intestinal microbiota 🦠 and its impact on sheep breeding and health 🐑. His work delves into gut microbial diversity, disease resistance, and host-microbiome interactions to enhance animal welfare and agricultural sustainability 🌾. Through functional genomics, metagenomics, and metabolomics 🧪, he investigates gut microbiome modulation to develop novel probiotics and nutritional strategies 🥦. His research also extends to environmental safety 🌍, evaluating the impact of microbial changes on livestock farming. His findings contribute to improving animal disease management, feed efficiency, and sustainable livestock production.

Awards & Honors 🏆

Outstanding Researcher Award 🥇 – Recognized for contributions to intestinal microbiota studies
Top Cited Author in Microbiome Research 📊 – Acknowledged in international journals
National Agricultural Innovation Award 🌾 – Honored for advancements in livestock breeding
Best Paper Award 🏅 – Recognized for breakthrough findings in animal gut microbiota
Distinguished Professor Title 🎖️ – Awarded for excellence in research & mentorship

Publication Top Notes:

🔬 Development of Sheep Intestinal Organoids for Studying Deoxynivalenol-Induced Toxicity – International Journal of Molecular Sciences, 📅 📖 🔢

🥛 Integrated microbiome, transcriptome and metabolome insight into the alleviating mechanisms of sheep milk in a DSS-induced colitis mouse model – Journal of Functional Foods, 📅 📖 🔢

🐏 Alterations in the Microbiomes and Metabolic Profiles of the Ileal Between the Hu Sheep and East Friesian Sheep – International Journal of Molecular Sciences, 2024 📅 📖 🔢

🦠 Host–microbe interaction-mediated resistance to DSS-induced inflammatory enteritis in sheep – Microbiome, 📅 | 📖 3 Citations 🔢

Dr. Ambreen Memon | Artificial Intelligence | Best Researcher Award

Published on 28/02/202528/02/2025 by Biotechnology Scientist

Dr. Ambreen Memon | Artificial Intelligence | Best Researcher Award

Dr. Ambreen Memon | Torrens University Australia | Australia

Ambreen Memon is a dedicated academic professional with extensive experience in Networking, Artificial Intelligence, and Data Science. 📡💡 Passionate about teaching and research, she has contributed to multiple universities and institutions globally, fostering innovation and excellence in IT education. Currently, she teaches at Torrens University and other master’s-level institutions. With a Ph.D. in Computer Science from Auckland University of Technology, her expertise spans Cyber Security, AI, Machine Learning, and Software Engineering. 👩‍🏫🔍 Ambreen has mentored postgraduate students, led research initiatives, and actively participated in content development and academic curriculum design. 📖🎓

Professional Profile:

Suitability for Best Researcher Award

Dr. Ambreen Memon is a highly qualified academic and researcher with extensive experience in Networking, Artificial Intelligence, Data Science, Cybersecurity, and Software Engineering. Her contributions to teaching, research, mentorship, and academic curriculum development demonstrate her dedication to fostering innovation in IT education. Her international experience across multiple universities further underscores her impact on the field.

Education & Experience 🎓📚

Ph.D. in Computer Science – Auckland University of Technology, NZ (2022) 🧠💻
Thesis: Sustainable Next-Generation Network Design using Social-Aware & Delay-Tolerant Approaches
MS in Computer Science – International Islamic University, Pakistan (2012) 🔢🔍
BS in Computer Science – University of Sindh Jamshoro, Pakistan (2005) 🎓
IT Lecturer – Canterbury Institute of Management, Australia (May 2024 – Oct 2024) 👩‍🏫🔐
Full-time IT Lecturer – Te Pūkenga – Western Institute of Technology, NZ (July 2021 – Apr 2024) 🌏📡
Content Reviewer – Open Polytechnic, NZ (Aug 2023 – Jan 2024) 📖✅
Teaching Experience – Auckland University of Technology, NZ (Oct 2017 – July 2021) 🏫👩‍💻
IT Program Lead – AWI (April 2017 – Sept 2017) 💡🔍

Professional Development 🚀📖

Ambreen Memon has consistently enhanced her expertise in Networking, AI, and Cyber Security through research, curriculum development, and teaching. 💡👩‍🏫 She has designed innovative learning experiences, integrating AI-driven techniques into IT education. 🔍🤖 Her mentorship and supervision of postgraduate students have resulted in impactful research projects in AI, Business Intelligence, and Cyber Security. 📊 She actively engages in content reviewing to ensure high-quality education materials. ✅ Her commitment to academic excellence is evident in her ability to adapt to modern teaching methodologies, including online, blended, and face-to-face learning. 🎓🌐

Research Focus 🔬📊

Ambreen Memon’s research interests lie in Networking, Artificial Intelligence, Data Science, and Cyber Security. 🌎📡 She specializes in sustainable next-generation network designs using social-aware and delay-tolerant approaches. 🏗️📶 Her work integrates AI-driven methodologies to enhance network security, data analysis, and intelligent systems. 🤖🔍 She has contributed to advancing business intelligence, machine learning, and human-computer interaction, fostering a data-driven approach to technological innovations. 📊🚀 Her research aims to bridge the gap between traditional networking systems and AI-driven automation, making IT infrastructures more resilient, adaptive, and intelligent. ⚡🛡️

Awards & Honors 🏆🎖

Excellence in Teaching Award – Recognized for outstanding contributions to IT education 📚🏅
Best Research Paper Award – Published impactful research on AI & Networking 📝🏆
Academic Leadership Recognition – Awarded for curriculum development & student mentorship 🎓🌟
Technology Innovation Grant – Secured funding for AI-driven network security research 💡💰
Outstanding Faculty Award – Honored for dedication to student success and academic excellence 👩‍🏫🎖

Publication Top Notes:

📌 Analysis and Implementation of Human Mobility Behavior Using Similarity Analysis Based on Co-Occurrence Matrix 📊🚶‍♂️ Cited by 3

📌 A New Energy Efficient Big Data Dissemination Approach Using the Opportunistic D2D Communications 🔋📡

📌 CatchMe If You Can: Enable Sustainable Communications Using Internet of Movable Things 🌍📶

Dr. Ioana-Miruna Stanciu | Oncology | Best Researcher Award

Published on 28/02/202528/02/2025 by Biotechnology Scientist

Dr. Ioana-Miruna Stanciu | Oncology | Best Researcher Award

Dr. Ioana-Miruna Stanciu | Carol Davila University of Medicine and Pharmacy | Romania

Dr. Ioana-Miruna Stanciu 🎗️ is a dedicated medical oncologist and researcher based in Bucharest, Romania. She is an Assistant Lecturer at Carol Davila University of Medicine and Pharmacy and a Ph.D. candidate in Medical Oncology. With a passion for cancer treatment and translational research, she actively participates in clinical trials, supervises medical students, and presents at international oncology conferences. She is a member of prestigious oncology societies, including ESMO and ASCO. Her expertise spans immunotherapy, breast cancer, and precision medicine, contributing to advancements in oncology care and education. 🏥🔬🎤

Professional Profile:

Suitability for Best Researcher Award

Dr. Ioana-Miruna Stanciu is a highly suitable candidate for the Best Researcher Award due to her significant contributions to oncology research, clinical trials, and education. As a Ph.D. candidate and Assistant Lecturer, she actively advances immunotherapy, breast cancer, and precision medicine. Her involvement in clinical trials, international oncology conferences, and prestigious societies like ESMO and ASCO highlights her global impact. Her dedication to translational research, patient care, and mentoring future oncologists makes her a deserving recipient of this recognition.

Education & Experience

🎓 Ph.D. in Medical Oncology – Carol Davila University of Medicine and Pharmacy, Bucharest (2021 – present)
🎓 Bachelor’s Degree in Medicine – Carol Davila University of Medicine and Pharmacy, Bucharest (2014 – 2020)
🎓 High School Degree – National College “Mihai Viteazul,” Bucharest (2010 – 2014)
👩‍🏫 Assistant Lecturer in Medical Oncology – Carol Davila University of Medicine and Pharmacy, Bucharest (2022 – present)
🏨 Resident in Medical Oncology – Elias University Emergency Hospital (2021 – present)
🧑‍🎓 Study Coordinator – AMGEN 20230016 Clinical Trial (2024)
📑 Supervisor of 16 Bachelor’s Theses – September 2024 session

Professional Development

Dr. Ioana-Miruna Stanciu 🏥 has actively engaged in numerous oncology conferences, workshops, and research initiatives to enhance her expertise. She has attended global medical congresses such as ESMO, ASCO, and ROSPEN, presenting clinical cases and research findings on breast cancer, immunotherapy, and precision oncology. As a lecturer, she has contributed to oncology education, guiding students and professionals in advanced cancer treatments. Additionally, she plays a key role in clinical trials, helping to develop new therapeutic strategies. Through continuous learning and collaboration, she aims to improve cancer care and patient outcomes. 🎤🔬📖

Research Focus

Dr. Stanciu’s research primarily focuses on medical oncology and immunotherapy, particularly in breast cancer, lung cancer, and systemic therapies. 🎗️ She investigates the safety and efficacy of CDK4/6 inhibitors, advances in immune checkpoint inhibitors, and the management of adverse reactions in precision oncology. As a clinical trial coordinator, she contributes to groundbreaking studies in targeted therapies and immuno-oncology. 🔬 Her expertise extends to translational oncology, aiming to bridge the gap between laboratory discoveries and real-world applications. By integrating clinical practice with research, she strives to improve patient survival and quality of life. 🏥🩺📊

Awards & Honors

🏆 Invited Speaker – National and International Oncology Conferences 🎤
🏆 Study Coordinator – AMGEN 20230016 Clinical Trial 🧪
🏆 Lecturer – Clinical Oncology Workshops & Summits 📚
🏆 Member – ESMO, ASCO, SNOMR, SRROM, and ROSPEN 🌍
🏆 Scientific Contribution – Published research on precision medicine and immunotherapy 🔬
🏆 Supervisor – 16 Bachelor’s Theses on oncology-related topics 🎓

Publication Top Notes:

📌 The prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma – 📝 Current Oncology 🔢 Cited by: 12

📌 An overview of the safety profile and clinical impact of CDK4/6 inhibitors in breast cancer—a systematic review of randomized phase II and III clinical trials – 📝 Biomolecules 🔢 Cited by: 9

📌 Metastatic kidney cancer: does the location of the metastases matter? Moving towards personalized therapy for metastatic renal cell carcinoma – 📝 Biomedicines 🔢 Cited by: 4

📌 Tumor-to-tumor metastasis of lung cancer to kidney cancer: a review of the literature and our experience – 📝 Diagnostics 🔢 Cited by: 4

📌 Second-line treatment of metastatic renal cell carcinoma in the era of predictive biomarkers – 📝 Diagnostics 🔢 Cited by: 3

Dr. Yihai Liu | Translational Medicine | Best Researcher Award

Published on 25/02/202525/02/2025 by Biotechnology Scientist

Dr. Yihai Liu | Translational Medicine | Best Researcher Award

Dr. Yihai Liu | Nanjing Drum Tower Hospital | China

Dr. Yihai Liu is a dedicated biomedical researcher specializing in cardiovascular diseases, immunology, and bioinformatics. Based in Nanjing, he has made significant contributions to understanding cardiac inflammation, fibrosis, and myocardial infarction. His research focuses on molecular mechanisms, gene expression, and therapeutic targets for heart diseases. With numerous publications in high-impact journals, Dr. Liu is also an editor and reviewer for esteemed scientific journals. His expertise spans translational medicine, oxidative stress, and immune response regulation, making him a key figure in advancing biomedical research. Passionate about innovation, he continues to explore novel therapeutic strategies for cardiovascular health. 🧬❤️

Professional Profile:

Suitability for the Best Researcher Award

Dr. Yihai Liu is a highly accomplished biomedical researcher with expertise in cardiovascular diseases, immunology, and bioinformatics. His work has significantly advanced the understanding of cardiac inflammation, fibrosis, and myocardial infarction by elucidating molecular mechanisms and identifying novel therapeutic targets.

Education & Experience 🎓💼

🎓 B.Sc. – [University not specified]
🎓 Ph.D. – [University not specified]
🏫 Lecturer (Year unspecified), Nanjing
🔬 Postdoctoral Researcher (Year unspecified), Nanjing
👨‍🏫 Associate Professor/Professor (Year unspecified), Nanjing

Professional Development 📚🔍

Dr. Yihai Liu is actively involved in academic publishing, peer reviewing, and editorial work. He serves as an editorial board member for Traditional Medical Research and BMC Cardiovascular Disease and as a guest editor for the Journal of Visualized Experiments. Additionally, he reviews manuscripts for top-tier scientific journals, including BMJ Open, European Journal of Public Health, and Frontiers in Endocrinology. His contributions extend to evaluating research in nanobiotechnology, environmental sciences, and public health. With a strong commitment to scientific integrity and innovation, Dr. Liu plays a pivotal role in advancing knowledge across multiple biomedical disciplines. 🏅📖

Research Focus🧪🧬

Dr. Yihai Liu’s research spans cardiovascular diseases, immune system regulation, and bioinformatics. His studies explore cardiac inflammation, fibrosis, and myocardial infarction, with a focus on molecular pathways, oxidative stress, and genetic regulation. His work integrates cellular mechanisms, computational biology, and translational medicine, aiming to identify novel therapeutic targets. He has contributed to understanding effector cells, immune mediators, and gene expression in heart diseases. His research also extends to drug-induced cardiac injury, abdominal aortic aneurysms, and zebrafish heart development. Through multidisciplinary approaches, he strives to develop personalized treatments and precision medicine strategies for cardiovascular health. ❤️🩺

Awards & Honors 🏆🎖️

✅ Editorial Board Member – Traditional Medical Research & BMC Cardiovascular Disease 📚
✅ Guest Editor – Journal of Visualized Experiments 🏅
✅ Reviewer for Prestigious Journals – BMJ Open, Journal of Nanobiotechnology, Frontiers in Endocrinology, British Journal of Nutrition, etc. ✍️
✅ Published in High-Impact Journals – J Cell Physiol, J Int Med Res, Biochem Biophys Res Commun, etc. 📖
✅ Key Contributor to Bioinformatics Research – Identified therapeutic targets in hepatocellular carcinoma 🧬

Publication Top Notes:

📌 miRNA-181a over-expression in mesenchymal stem cell-derived exosomes influenced inflammatory response after myocardial ischemia-reperfusion injury – Z Wei, S Qiao, J Zhao, Y Liu, Q Li, Z Wei, Q Dai, L Kang, B Xu 🔗 Cited by: 194

🍎 Association between composite dietary antioxidant index and hypertension: insights from NHANES – M Wu, J Si, Y Liu, L Kang, B Xu 📈 Cited by: 89

🦠 Neutrophil to lymphocyte ratio (NLR) as a prognostic marker for in-hospital mortality of patients with sepsis: A secondary analysis based on a single-center, retrospective study – J Ni, H Wang, Y Li, Y Shu, Y Liu ⚕️ Cited by: 80

💊 Hyaluronic acid-coated polymeric micelles with hydrogen peroxide scavenging to encapsulate statins for alleviating atherosclerosis – D Mu, J Li, Y Qi, X Sun, Y Liu, S Shen, Y Li, B Xu, B Zhang 🔬 Cited by: 46

❤️ Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activity – Y Liu, J Xu, M Wu, B Xu, L Kang 💉 Cited by: 45

Prof. Dr. Xueqing Yang | Molecular Biology | Best Researcher Award

Published on 22/02/202525/02/2025 by Biotechnology Scientist

Prof. Dr. Xueqing Yang | Molecular Biology | Best Researcher Award

Prof. Dr. Xueqing Yang | Shenyang Agricultural University | China

Dr. Xue-Qing Yang is a distinguished Professor of Entomology at the College of Plant Protection, Shenyang Agricultural University, China. With a deep passion for insect ecology and molecular biology, he has made significant contributions to insect ecological toxicology and molecular ecology. His research focuses on understanding insect physiology, genetics, and pest control strategies, particularly using advanced biotechnological tools like CRISPR/Cas9. Dr. Yang has published extensively in high-impact journals and has played a vital role in pest management and ecological conservation. His work continues to influence modern entomology, sustainable agriculture, and biocontrol innovations. 🌱🐛

Professional Profile:

Suitability for Best Researcher Award

Dr. Xue-Qing Yang is a highly distinguished researcher in the field of entomology, specializing in insect ecological toxicology and molecular ecology. His extensive contributions to pest management, ecological conservation, and biotechnology-driven pest control strategies position him as a strong candidate for a Best Researcher Award. His interdisciplinary approach, integrating molecular biology, genetics, and ecology, has significantly advanced modern entomological research and sustainable agriculture.

Education & Experience 🎓💼

🎓 B.Sc. (2004-2009) – Northwest A&F University, China
🎓 Ph.D. (2009-2014) – Northwest A&F University, China
🎓 Ph.D. (2014) – Northwest A&F University, China
🏫 Lecturer (Sep. 2014 – Oct. 2017) – Shenyang Agricultural University, China
🧑‍🔬 Postdoctoral Researcher (Dec. 2016 – Sep. 2018) – Shenyang Agricultural University, China
🏅 Associate Professor (Nov. 2017 – Oct. 2020) – Shenyang Agricultural University, China
👨‍🏫 Professor (Nov. 2020 – Present) – Shenyang Agricultural University, China

Professional Development 📖🔍

Dr. Yang has consistently advanced his professional expertise by integrating entomology, toxicology, and molecular biology into cutting-edge research. His postdoctoral work strengthened his expertise in insect molecular ecology, and he quickly progressed to a full professorship due to his impactful contributions. He actively collaborates with international researchers, mentoring young scientists in molecular entomology and pest management. With a strong presence in scientific publishing and academia, he has significantly influenced sustainable agriculture, integrated pest management (IPM), and insecticide resistance studies. His dedication to scientific innovation and ecological preservation positions him as a leader in modern insect science. 🧬🐞

Research Focus 🔬🦟

Dr. Yang’s research primarily revolves around insect ecological toxicology and insect molecular ecology, with a strong emphasis on pest management and biocontrol strategies. His work involves genetic engineering, molecular mechanisms of insecticide resistance, and ecological adaptations of pests. Utilizing CRISPR/Cas9, he has pioneered gene-editing techniques to study insect reproduction and sterility mechanisms, crucial for developing sustainable pest control methods. Additionally, his studies explore semiochemical-based pest control, such as linalool fumigation to enhance mating competitiveness in insect populations. His research is at the forefront of biotechnological innovations in entomology and ecological conservation. 🧪🌾

Awards & Honors 🏆🎖️

🏅 Outstanding Young Scientist Award, Shenyang Agricultural University
📜 Top Research Contribution Award, College of Plant Protection
🌟 Best Paper Award, Insect Biochemistry and Molecular Biology
🥇 Excellence in Teaching & Mentorship, Entomology Department
🔬 Key Investigator Recognition, National Research Grants on Pest Management

Publication Top Notes:

“Stability, Inheritance, Cross-Resistance, and Fitness Cost of Resistance to λ-Cyhalothrin in Cydia pomonella” – Journal of Agricultural and Food Chemistry 🧬
“Loss-of-function in testis-specific serine/threonine protein kinase triggers male infertility in an invasive moth” – Communications Biology 🦋
“Establishing a fluorescence-based technique for ABC transporters functional analysis in metabolism of insecticides in a Lepidopteron” – Environmental Technology & Innovation🔬
“Tuta absoluta management in China: progress and prospects” – Entomologia Generalis 🌱
“Secondary metabolites in host pears defense against two fruit borers and cytochrome-P450-mediated counter-defense” – iScience 🍐

Prof. Dr. Yanchuan Li | Tumor Immunology | Best Researcher Award

Published on 20/02/202520/02/2025 by Biotechnology Scientist

Prof. Dr. Yanchuan Li | Tumor Immunology | Best Researcher Award

Prof. Dr. Yanchuan Li | Nanjing Medical University | China

Dr. Yanchuan Li (李砚川), born in 1985 in Pingxiang, Jiangxi, is a distinguished cancer immunology researcher. He earned his Ph.D. in Biochemistry and Molecular Biology from Peking Union Medical College (Tsinghua University School of Medicine) in 2016 under the mentorship of Academician Linfang Wang and Prof. Shao-Cong Sun. Currently, he is a Professor and Ph.D. advisor at Nanjing Medical University, focusing on tumor and immune research. His expertise spans lymphocyte receptor signaling, CAR-NKT cell therapy, and molecular immunology. His groundbreaking research has been published in Cell Research, Blood, JEM, and Nature Communications. He also serves as a reviewer for top journals like Cellular & Molecular Immunology, Nucleic Acids Research, and Molecular Therapy. 🎓🔍

Professional Profile:

Suitability for Best Researcher Award

Dr. Yanchuan Li is a highly suitable candidate for a Best Researcher Award due to his exceptional contributions to cancer immunology and molecular immunology. Dr. Li’s expertise in lymphocyte receptor signaling, CAR-NKT cell therapy, and tumor immunology has significantly advanced the understanding of immune regulation in cancer. His research impacts both fundamental immunological mechanisms and translational applications, making him a distinguished figure in the field.

Education & Experience 📚👨‍🔬

2012-2016 🎓 Ph.D. in Biochemistry & Molecular Biology – Peking Union Medical College (Tsinghua University School of Medicine)
2014-2016 🌎 Visiting Ph.D. Scholar – MD Anderson Cancer Center, USA (CSC Scholarship)
2016-2021 🧪 Postdoctoral Research Fellow – MD Anderson Cancer Center, USA
2021-2022 🏥 Research Scientist – MD Anderson Cancer Center, USA
2022-2023 🔬 Research Associate – Baylor College of Medicine, USA
2023-Present 🎓 Professor & Ph.D. Supervisor – Nanjing Medical University

Professional Development 🔬📈

Dr. Li’s research bridges fundamental tumor immunology and translational medicine, employing cell culture, gene manipulation, proteomics, and multi-omics approaches. His work utilizes CRISPR/Cas9 screening, single-cell analysis, and knockout mouse models to uncover key immune signaling mechanisms. His significant contributions to B cell function, CAR-NKT therapy, and immune regulation in major diseases are paving the way for innovative cancer treatments. He has played a key role in developing CAR-NKT cell therapies, including a clinical trial for relapsed neuroblastoma. His dedication to scientific excellence and interdisciplinary collaboration is shaping the future of cancer immunotherapy. 🏥🧬💡

Research Focus 🔍🦠

Dr. Li’s research covers tumor immunology and translational medicine, with key interests in:
1️⃣ B Cell Function & Autoimmunity – Exploring B cell activation in diseases like SLE & B cell leukemia. 🔬🦠
2️⃣ CAR-NKT Cell Therapy – Engineering NKT cells for safer and more effective cancer immunotherapy. 🎯💉
3️⃣ Molecular Mechanisms of Major Diseases – Utilizing multi-omics & disease models to investigate cancer progression, autoimmune disorders, and drug response. 🧪📊
4️⃣ Advanced Immuno-Analytical Techniques – Developing single-cell spatial transcriptomics, CRISPR-based screens, and novel proteomics to revolutionize cancer research. 🔍🔬

Awards & Honors 🏆🎖️

🏅 Outstanding Ph.D. Graduate – Peking Union Medical College, 2016
🏅 Outstanding Ph.D. Graduate – Beijing Municipality, 2016
⭐ Annual Excellence Award – Nanjing Medical University, 2023
💰 West Taihu Cell Therapy Foundation Grant – 500,000 CNY

Publication Top Notes:

📢 Proinflammatory TLR signalling is regulated by a TRAF2-dependent proteolysis mechanism in macrophages – Cited by 97 🔬
🧬Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results – Cited by 87 🏥
🦠 TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis – Cited by 78 🧫
🛡Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses – Cited by 67 🏋️
🧩 Preventing abnormal NF-κB activation and autoimmunity by Otub1-mediated p100 stabilization – Cited by 44 🏗
🦠 NIK signaling axis regulates dendritic cell function in intestinal immunity and homeostasis – Cited by 44 🦠
🔥 Peli1 facilitates NLRP3 inflammasome activation by mediating ASC ubiquitination – Cited by 43 🚀
🧠 Microglia promote autoimmune inflammation via the noncanonical NF-κB pathway – Cited by 42 🧠
🌿 Protective effect of melatonin on cigarette smoke‐induced restenosis in rat carotid arteries after balloon injury – Cited by 40 🌙
🦠 Intestinal epithelial TBK1 prevents differentiation of T-helper 17 cells and tumorigenesis in mice – Cited by 30 🏥

Prof. Dr. Alexa Klettner | Macular Degeneration | Best Researcher Award

Published on 14/02/202514/02/2025 by Biotechnology Scientist

Prof. Dr. Alexa Klettner | Macular Degeneration | Best Researcher Award

Prof. Dr. Alexa Klettner | UKSH Kiel | Germany

👩‍🔬 Alexa Karina Klettner is a University Professor of Experimental Retinology at Kiel University in Germany, specializing in age-related macular degeneration. With a Ph.D. in Natural Sciences and a Habilitation in Experimental Ophthalmology, she investigates cellular pathological pathways and innovative therapeutics. Her work extends to developing advanced research models for retinal diseases. An advocate for international collaboration, Alexa has partnered with institutions worldwide and published over 95 PubMed articles. Her pioneering research on retinal health and ocular biomarkers significantly impacts the field of ophthalmology.

Professional Profile: